Related Experiment Video
Updated: Feb 25, 2026

Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
Published on: September 20, 2020
Increased dopamine release after working-memory updating training: Neurochemical correlates of transfer
Lars Bäckman1, Otto Waris2, Jarkko Johansson3
1Aging Research Center, Karolinska Institute, Stockholm, Sweden. lars.backman.1@ki.se.
Abstract:
Previous work demonstrates that working-memory (WM) updating training results in improved performance on a letter-memory criterion task, transfers to an untrained n-back task, and increases striatal dopamine (DA) activity during the criterion task. Here, we sought to replicate and extend these findings by also examining neurochemical correlates of transfer. Four positron emission tomography (PET) scans using the radioligand raclopride were performed. Two of these assessed DAD2 binding (letter memory; n-back) before 5 weeks of updating training, and the same two scans were performed post training. Key findings were (a) pronounced training-related behavioral gains in the letter-memory criterion task, (b) altered striatal DAD2 binding potential after training during letter-memory performance, suggesting training-induced increases in DA release, and (c) increased striatal DA activity also during the n-back transfer task after the intervention, but no concomitant behavioral transfer. The fact that the training-related DA alterations during the transfer task were not accompanied by behavioral transfer suggests that increased DA release may be a necessary, but not sufficient, condition for behavioral transfer to occur.
More Related Videos
Related Concept Videos
Working Memory
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Higher Mental Functions of Brain: Learning and Memory
Long-term Potentiation
Long-term Potentiation
Hebbian LTP
LTP can occur when...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

